{"schema_version":"1","generated_at":"2026-11-02T18:15:26.398Z","data_as_of":null,"url":"https://www.findmykol.com/kol/raya-saba","json_url":"https://www.findmykol.com/kol/raya-saba/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"raya-saba","name":"Raya Saba","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Washington University in St. Louis","institution_url":"https://www.findmykol.com/institution/washington-university-school-of-medicine-in-st-louis","city":"Saint Louis","state":"MO","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1902154743","orcid":"0000-0002-5955-2390","openalex":"A5047921040"},"summary":"Raya Saba is an Oncology physician affiliated with Washington University in St. Louis. OpenAlex indexes 85 publications with 463 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":85,"cited_by_count":463,"h_index":11,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":29,"program_years":{"first":2021,"last":null},"rows_total":30,"shown":3,"withheld":27,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":2369.56,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902154743"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":57.24,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902154743"},{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":53.18,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902154743"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1902154743","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":42,"classes_total":4,"classes":[{"class":"Thalidomide Analog","setting":"prescribed","share_pct":14.5,"drugs":[{"name":"Revlimid","share_pct":100}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":12.3,"drugs":[{"name":"Jakafi","share_pct":52.9},{"name":"Brukinsa","share_pct":47.1}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":26.1,"classes_total":2,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":20.3,"drugs":[{"name":"Xarelto","share_pct":55.4},{"name":"Eliquis","share_pct":44.6}],"max_beneficiaries":null},{"class":"Vitamin K antagonist","setting":"prescribed","share_pct":5.8,"drugs":[{"name":"Warfarin Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":15.2,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":15.2,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":15}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Outcomes of Autologous Stem Cell Transplant in Older Adults with Relapsed/Refractory Classic Hodgkin Lymphoma","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-199845","status":"verified"},{"title":"8. Reduced subclone diversity in clonal cytopenia of undetermined significance compared to myelodysplastic syndrome","year":2024,"journal":"Cancer Genetics","source_url":"https://doi.org/10.1016/j.cancergen.2024.08.010","status":"verified"},{"title":"Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma","year":2023,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.26827","status":"verified"},{"title":"Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era","year":2023,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2023011205","status":"verified"},{"title":"Phase II Trial of Duvelisib Maintenance after Autologous Stem Cell Transplant in T-Cell and B-Cell Non-Hodgkin Lymphomas: Results of Safety Lead in","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2023-174109","status":"verified"}],"source":"works"},"contact":{"address_1":"10050 KENNERLY RD STE 2400","city":"Saint Louis","state":"MO","zip":"631282193","phone":"314-849-6066","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1902154743","source":"identity"},"similar":[{"name":"Randall Bateman","slug":"randall-bateman","institution":"Washington University in St. Louis","specialty":"Neurology","url":"https://www.findmykol.com/kol/randall-bateman","json_url":"https://www.findmykol.com/kol/randall-bateman/profile.json"},{"name":"Janet McGill","slug":"janet-mcgill","institution":"Washington University in St. Louis","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/janet-mcgill","json_url":"https://www.findmykol.com/kol/janet-mcgill/profile.json"},{"name":"Robert Carney","slug":"robert-carney","institution":"Washington University in St. Louis","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/robert-carney","json_url":"https://www.findmykol.com/kol/robert-carney/profile.json"},{"name":"David Clifford","slug":"david-clifford","institution":"Washington University in St. Louis","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-clifford","json_url":"https://www.findmykol.com/kol/david-clifford/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":27,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-08-12","provider_certified":"2025-08-12","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}